Govt developing multi-variant Covid-19 vaccine

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus,......

3rd wave: Govt creating 30-day stock of key Covid medicines

'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What’s better is that this time, the government is paying us in advance,' said a senior executive......

Covid vaccines for children likely by Sept: AIIMS chief

Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences director Randeep Guleria......

Govt waives import duty on Remdesivir

Amid surging COVID-19 cases in the country, the government on Tuesday waived customs duty on Remdesivir, its raw materials and other components used to make the antiviral drug. The move would help......

Share of family-owned firms in total market capitalisation rises to 64.5%

The growth was led by family-owned companies and business groups with presence in pharmaceuticals, information technology services, and consumer products. Illustration: Dominic Xavier/Rediff.com......

How Indian pharma bounced back from lockdown lows

From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies — Indian drug makers have......

Air freight stations planned to transport Covid vaccines

The government is considering setting up air freight stations to enable direct movement of vaccines from pharmaceutical factories to the aircraft. From reducing dwell time at airports to faster......

4 Indian drug firms recall products in US market

Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus  and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug......